Hence, there are no strong clinical trials showing that herbal GLP-1 patches are effective for diabetes or weight loss
The key question now is: Are GLP-1 agonists directly reducing inflammation by acting on the immune system
Most importantly, it provides advice and tools to aid clinicians in selecting suitable alternatives to GLP-1 RAs where there is limited availability
Foundayo is FDA-approved for adults with a BMI of 30 or greater (obesity), or a BMI of 27 or greater with at least one weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes
Daily dosing would risk supratherapeutic accumulation and is not supported by the published pharmacokinetic data
Mima A, Hiraoka-Yamomoto J, Li Q, Kitada M, Li C, Geraldes P, Matsumoto M, Mizutani K, Park K, Cahill C, et al